PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer)
Conditions
- Cancer
- Carcinoma
- Head and Neck Cancer
- Metastases
- Metastatic Cancer
- Metastatic or Recurrent Squamous Cell Carcinoma of Head and Neck
- Oncology
- Squamous Cell Carcinoma
- Tumors
Interventions
Sponsor
Amgen